<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Reports of Biochemistry and Molecular Biology</title>
<title_fa></title_fa>
<short_title>rbmb.net</short_title>
<subject>Basic Sciences</subject>
<web_url>http://rbmb.net</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-3480</journal_id_issn>
<journal_id_issn_online>2322-3480</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/rbmb</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>More Related Gene Pathways to Vincristine-Induced Death Events in a Human T-Acute Lymphoblastic Leukemia Cell Line</title>
	<subject_fa>زیست شناسی ملکولی</subject_fa>
	<subject>Molecular Biology</subject>
	<content_type_fa>مقالات اصلی</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Background:&lt;/em&gt;&lt;/strong&gt; Acute lymphoblastic leukemia (ALL) is common in children but rare in adults. Vincristine&amp;nbsp;(VCR) is one of the drugs used at the beginning of treatment. Some genes are resistant to VCR in B-ALL.&amp;nbsp;&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Methods:&lt;/em&gt;&lt;/strong&gt; Here, we examined the effect of VCR on gene expression changes in a T-ALL cell line, Jurkat.&amp;nbsp;The MTT method was used to determine the IC50 in Jurkat cells treated with different concentrations of&amp;nbsp;VCR for 48 and 72 hours. Total RNA was isolated from the cells and cDNA was prepared. The Human&lt;br&gt;
Cancer Drug Target PCR Array kit was used to evaluate the 84 gene expression changes in Jurkat cells.&amp;nbsp;Protein-protein interaction was analyzed by STRING software.&lt;br&gt;
&lt;br&gt;
&lt;em&gt;&lt;strong&gt;Results:&lt;/strong&gt;&lt;/em&gt; We identified 66 differentially expressed genes as comparison to untreated cells. The response to&amp;nbsp;VCR-induced apoptotic events was remarkable in the pathways of heat shock protein, topoisomerase,&amp;nbsp;protein kinases, cathepsins and cell cycle. In other pathways, there were resistant genes as well as sensitive&amp;nbsp;genes to VCR treatment. Some proteins like HSP90AA1 and ESR1 had determining associations with other&amp;nbsp;proteins.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Conclusions&lt;/em&gt;&lt;/strong&gt;: The results suggest VCR target genes in T-ALL cells may be beneficial biomarkers for&amp;nbsp;ALL treatment and can be used to select appropriate synergistic drugs for VCR.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>ALL, Gene expression profile, Jurkat, PCR array, Vincristine.</keyword>
	<start_page>554</start_page>
	<end_page>564</end_page>
	<web_url>http://rbmb.net/browse.php?a_code=A-10-830-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Azam</first_name>
	<middle_name></middle_name>
	<last_name>Rashidbaghan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012410</code>
	<orcid>100319475328460012410</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali</first_name>
	<middle_name></middle_name>
	<last_name>Mostafaie</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ali_mostafaie@kums.ac.ir.</email>
	<code>100319475328460012411</code>
	<orcid>100319475328460012411</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Yaghoub</first_name>
	<middle_name></middle_name>
	<last_name>Yazdani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012412</code>
	<orcid>100319475328460012412</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
